Medical management of glaucoma: Principles and practice

Kuldev Singh, Anurag Shrivastava

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Glaucoma care is more an art than science. The introduction of several new classes of glaucoma medications and the completion of many large randomized clinical trials have not changed this fact. While we now have better choices when initiating glaucoma therapy relative to our predecessors, the principles of glaucoma therapy have not changed much during this period. Debates continue regarding the utility of concepts such as "the monocular therapeutic trial," "target intraocular pressure (IOP)," and "maximal medical therapy." Our tools for detecting and following glaucomatous disease have improved but are not precise enough for us to prospectively predict which patients will do better or worse than others. Much attention has been given to disease stage, rate of progression, and compliance with medications but regular patient follow-up, an area that has received little attention, may be among the most important predictors of patient outcomes.

Original languageEnglish (US)
JournalIndian Journal of Ophthalmology
Volume59
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 2011

Fingerprint

Glaucoma
Medication Adherence
Therapeutics
Art
Intraocular Pressure
Randomized Controlled Trials

Keywords

  • Glaucoma
  • maximal medical therapy
  • medical management
  • target intraocular pressure

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Medical management of glaucoma : Principles and practice. / Singh, Kuldev; Shrivastava, Anurag.

In: Indian Journal of Ophthalmology, Vol. 59, No. SUPPL. 1, 01.2011.

Research output: Contribution to journalArticle

@article{fd05412e9bf94c178f4ef6c43ad7dd65,
title = "Medical management of glaucoma: Principles and practice",
abstract = "Glaucoma care is more an art than science. The introduction of several new classes of glaucoma medications and the completion of many large randomized clinical trials have not changed this fact. While we now have better choices when initiating glaucoma therapy relative to our predecessors, the principles of glaucoma therapy have not changed much during this period. Debates continue regarding the utility of concepts such as {"}the monocular therapeutic trial,{"} {"}target intraocular pressure (IOP),{"} and {"}maximal medical therapy.{"} Our tools for detecting and following glaucomatous disease have improved but are not precise enough for us to prospectively predict which patients will do better or worse than others. Much attention has been given to disease stage, rate of progression, and compliance with medications but regular patient follow-up, an area that has received little attention, may be among the most important predictors of patient outcomes.",
keywords = "Glaucoma, maximal medical therapy, medical management, target intraocular pressure",
author = "Kuldev Singh and Anurag Shrivastava",
year = "2011",
month = "1",
doi = "10.4103/0301-4738.73691",
language = "English (US)",
volume = "59",
journal = "Indian Journal of Ophthalmology",
issn = "0301-4738",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Medical management of glaucoma

T2 - Principles and practice

AU - Singh, Kuldev

AU - Shrivastava, Anurag

PY - 2011/1

Y1 - 2011/1

N2 - Glaucoma care is more an art than science. The introduction of several new classes of glaucoma medications and the completion of many large randomized clinical trials have not changed this fact. While we now have better choices when initiating glaucoma therapy relative to our predecessors, the principles of glaucoma therapy have not changed much during this period. Debates continue regarding the utility of concepts such as "the monocular therapeutic trial," "target intraocular pressure (IOP)," and "maximal medical therapy." Our tools for detecting and following glaucomatous disease have improved but are not precise enough for us to prospectively predict which patients will do better or worse than others. Much attention has been given to disease stage, rate of progression, and compliance with medications but regular patient follow-up, an area that has received little attention, may be among the most important predictors of patient outcomes.

AB - Glaucoma care is more an art than science. The introduction of several new classes of glaucoma medications and the completion of many large randomized clinical trials have not changed this fact. While we now have better choices when initiating glaucoma therapy relative to our predecessors, the principles of glaucoma therapy have not changed much during this period. Debates continue regarding the utility of concepts such as "the monocular therapeutic trial," "target intraocular pressure (IOP)," and "maximal medical therapy." Our tools for detecting and following glaucomatous disease have improved but are not precise enough for us to prospectively predict which patients will do better or worse than others. Much attention has been given to disease stage, rate of progression, and compliance with medications but regular patient follow-up, an area that has received little attention, may be among the most important predictors of patient outcomes.

KW - Glaucoma

KW - maximal medical therapy

KW - medical management

KW - target intraocular pressure

UR - http://www.scopus.com/inward/record.url?scp=78650810597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650810597&partnerID=8YFLogxK

U2 - 10.4103/0301-4738.73691

DO - 10.4103/0301-4738.73691

M3 - Article

C2 - 21150040

AN - SCOPUS:78650810597

VL - 59

JO - Indian Journal of Ophthalmology

JF - Indian Journal of Ophthalmology

SN - 0301-4738

IS - SUPPL. 1

ER -